Concortis BiotherapeuticsLogo Design Contest
Logo Design Contest
Contests / Concortis Biotherapeutics
Concortis Biotherapeutics has selected their winning logo design.
For $375 they received 69 designs
from 23 different designers from around the world.
Logo Design Brief
Edit
Client
What We Do
Concortis Biotherapeutics is a biopharmaceutical company focused on
developing next generation Antibody Drug Conjugate for treatment of various
cancers. Concortis has a variety of proprietary methods for drug development.
developing next generation Antibody Drug Conjugate for treatment of various
cancers. Concortis has a variety of proprietary methods for drug development.
Industry
Color Preferences
Blues and greens, but other colors also welcome
Our Ideas & Additional Information
K-LockTM (site-specifically link Toxin to Lysine residual of antibody) and
C-LockTM (select link Toxin to an antibody through disulfide bond in the
hinge region) conjugation methods are our unique chemical methods to link
toxin to antibody on site-specific way, it would nice to somehow to link the
logo to our technology.
Please see: http://www.concortis.com/technology/c-lock
http://www.concortis.com/technology/k-lock
C-LockTM (select link Toxin to an antibody through disulfide bond in the
hinge region) conjugation methods are our unique chemical methods to link
toxin to antibody on site-specific way, it would nice to somehow to link the
logo to our technology.
Please see: http://www.concortis.com/technology/c-lock
http://www.concortis.com/technology/k-lock
Themes
Masculine
Complex
Colorful
Modern
Entries
1st
Withdrawn
2nd
Withdrawn
3rd
Withdrawn
4th
Withdrawn
5th
Withdrawn
6th
7th
8th
Withdrawn
9th
Withdrawn
10th
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
New
Withdrawn
New
New
New
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Removed
New
Removed
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Withdrawn
New
Prefers others.
Prefers others.
Prefers others.
Prefers others.
Withdrawn
Prefers others.
Withdrawn
Prefers others.
Withdrawn
Prefers others.
Withdrawn
Prefers others.
Withdrawn
Prefers others.
Withdrawn
Prefers others.
Withdrawn
Prefers others.
Withdrawn
Prefers others.
Withdrawn
Prefers others.